Get started
Author

Harit Kasana

Observed names: Kasana, Harit, Kasana, Harit; Jr.Scientist, National Institute of Biologicals(Ministry of Health and Family Welfare, Government of India)A-32, Sector-62, Noida-201 309, Kasana, Harit; National Institute of Biologicals(Ministry of Health and Family Welfare, Government of India)A-32, Sector-62, Noida-201 309
ORCID: 0000-0001-9315-7784
Observed ORCID: 0000-0001-9315-7784
OpenAlex ID: A5080872888
Prognostic significance of CHAC1 expression in breast cancer
2022 · Vikrant Mehta, Jaipal Meena, et al. · Molecular Biology Reports · 26
Clotrimazole as a new frontier: Drug repurposing and its efficacy in cancer therapy
2025 · Shubham C. Karpe, Manjula Kiran, et al. · Cancer Pathogenesis and Therapy · 9
A Systematic Review of Regulatory requirements of Biosimilar Products: WHO, India, European Union and USFDA
2024 · Harit Kasana, Harish Chander, et al. · Research Journal of Pharmacy and Technology · 3
Database analysis reveals endophilin A expression as a marker of metastasis and prognosis in breast cancer
2025 · Vikrant Mehta, Sohidul Islam, et al. · Discover Oncology · 2
PDF
Quality Management System in Testing Laboratories
2015 · Gaurav Pratap Singh Jadaun, Harit Kasana, et al. · 2
Advancing Rabies Control in India: The Crucial Role of QC in Vaccine Provision and Public Health Initiatives
2026 · Venkatesh Anand Iyer, Golam Md Mowazzim, et al. · Research Journal of Pharmacy and Technology · 1
Design and Development of Machine Learning Model for Antibody Design: Rituximab a Case Study
2024 · Harit Kasana, Harish Chander, et al. · Current Trends in Biotechnology and Pharmacy · 1
Technological advancement in the development of monoclonal antibody therapies: Present, past, and future
2024 · Harit Kasana, Harish Chander, et al. · Journal of Applied Biology & Biotechnology · 1
PDF
Comparative Evaluation of HEP-2(Cincinnati) and Vero cell lines sensitivity to Bivalent Oral Polio Virus Vaccine (Type 1 and Type 3) by using In-vitro Microtitration Potency Assay
2023 · Surekha Surekha, Anoop Kumar, et al. · Research Journal of Pharmacy and Technology · 1
Toxicity of Aluminum Adjuvant in Rabies Vaccine: A Case Study
2023 · Subhash Chand, Dr Jaipal Meena, et al. · SSRN Electronic Journal · 1
Rabies: a brief note on diagnostics and prophylactics
2026 · Farha Deeba, Jaipal Meena, et al. · VirusDisease
Current Quality Evaluation Landscape of Rotavirus Vaccines: A Comprehensive Review
2026 · Shubham C. Karpe, Manjula Kiran, et al. · Journal of Pure and Applied Microbiology
Challenges in Ensuring the Safety of Aluminum Adjuvanted Vaccine: A Case Study of Inactivated Rabies Vaccines by National Control Laboratory
2024 · Jaipal Meena, Faraz Shiekh, et al. · Preprints.org
Development of Optimized Strategy for Cloning, Expression and Analysis of a Recombinant Anti-CD20 Therapeutic Monoclonal Antibody in HEK-293 Cells
2024 · Harit Kasana, Harish Chander, et al. · Journal of Biotechnology & Bioinformatics Research
PDF
In-silico Rituximab Protein Engineering to Improve Humanization and Reduce Immunogenicity
2024 · Ashwani Mathur, Harish Chander, et al. · International Journal of Bioinformatics Research and Applications
Quality Testing for Vaccines: Need of the Hour
2023 · Harit Kasana, Dr Jaipal Meena, et al. · SSRN Electronic Journal
SARS-CoV-2 spike protein expression as an identification in quality control testing for Adenovector based COVID-19 vaccine
2023 · Harit Kasana, Ajay Kumar Ade, et al. · Journal of Immunological Methods
Analysis of market trend of Human Albumin and Coagulation factors in India
2019 · Shalini, Swati, Srivastava, Rashmi, et al. · International Journal of Biomedical and Advance Research
PDF
Improved Spectrophotometric Pharmacopoeial Method for accurate Quantitation of Thiomersal content in Haemophilus influenzae type b (Hib)-TT Conjugate Vaccine
2016 · Malik, Neeraj; Scientist Grade II, National Institute of Biologicals(Ministry of Health and Family Welfare, Government of India)A-32, Sector-62, Noida-201 309, Kasana, Harit; Jr.Scientist, National Institute of Biologicals(Ministry of Health and Family Welfare, Government of India)A-32, Sector-62, Noida-201 309, et al. · International Journal of Biomedical and Advance Research
PDF
Evaluation of BCG Vaccine in Excessive Dermal Reactivity Test
2015 · Kasana, Harit; National Institute of Biologicals(Ministry of Health and Family Welfare, Government of India)A-32, Sector-62, Noida-201 309, Suchitra, .; National Institute of Biologicals(Ministry of Health and Family Welfare, Government of India)A-32, Sector-62, Noida-201 309, et al. · International Journal of Biomedical and Advance Research
PDF
Trastuzumab: Antineoplastic agent; a recombinant DNA-derived humanized anti-HER2 monoclonal antibody
2015 · Harit Kasana · International journal of applied research
Production and Partial Purification of Xylanase from Bacillus pumilus
2015 · Harsh Chaudhary, Veenu Chaudhary, et al. · International Journal of Multidisciplinary Research and Development
Infliximab: Biological response modifier, chimeric IgG1 therapeutic recombinant monoclonal antibody
2015 · Harit Kasana · European Journal of Biotechnology and Bioscience
Works count: 23
Citation count: 46
H-index: 3
I10-index: 1
Year
Topic
Type